Correlation Between Emergent Biosolutions and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Emergent Biosolutions and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Emergent Biosolutions and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Takeda Pharmaceutical.

Diversification Opportunities for Emergent Biosolutions and Takeda Pharmaceutical

-0.91

Correlation Coefficient

Emergent Biosolutions  Takeda Pharmaceutical

Pay attention - limited upside

The 3 months correlation between Emergent and Takeda is -0.91. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Takeda Pharmaceutical

Considering the 90-day investment horizon Emergent Biosolutions is expected to under-perform the Takeda Pharmaceutical. In addition to that, Emergent Biosolutions is 3.87 times more volatile than Takeda Pharmaceutical Co. It trades about -0.23 of its total potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.2 per unit of volatility. If you would invest  1,317  in Takeda Pharmaceutical Co on December 29, 2024 and sell it today you would earn a total of  188.00  from holding Takeda Pharmaceutical Co or generate 14.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Emergent Biosolutions  vs.  Takeda Pharmaceutical Co

Emergent Biosolutions

Risk-Adjusted Performance

Very Weak

Over the last 90 days Emergent Biosolutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Takeda Pharmaceutical

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Takeda Pharmaceutical Co are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain basic indicators, Takeda Pharmaceutical disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Emergent Biosolutions and Takeda Pharmaceutical

The main advantage of trading using opposite Emergent Biosolutions and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind Emergent Biosolutions and Takeda Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.